(MedPage Today) — Use of a PCSK9 inhibitor to lower lipid levels was linked with significantly better survival in patients with certain cancers treated with immune checkpoint inhibitors (ICIs), a matched-cohort study showed.
Treatment with a…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
